基于Cite Space的临床路径效果研究可视化分析

Cite Space-based visual analysis of clinical pathway effectiveness studies

目的 以可视化方式展示国内外临床路径效果研究领域的研究现状、热点和趋势,为我国临床路径研究提供方向和参考。方法 统计分析CNKI和Web of Science数据库自建库至2022年6月1日发表的关于临床路径效果研究的中(英)文献进行检索,运用CiteSpace5.8.R3软件对有效文献的作者、机构和关键词进行可视化比较分析。结果 共纳入中文文献264篇,英文文献174篇,分析发现:(1)国内发文量呈先上升后下降的趋势,国外发文量总体比较稳定;(2)国内临床路径效果研究多为独立的状态,国外则形成了较为紧密的合作关系;(3)国内的研究热点主要是健康教育、效果评价、住院费用、住院时间等,国外的研究热点主要是临床路径指南、住院费用、临床护理路径等;(4)中文文献临床路径效果研究可分为3个演变阶段:起步阶段(2002年—2008年)、探索阶段(2009年—2016年)、发展阶段(2017年—2022年),英文文献可分为2个演变阶段:起步阶段(2003年—2011年)、发展阶段(2012年—至今)。结论 我国应该深化信息化管理研究、借助DRG改革赋能、推广老年人护理路径、进一步拓展试用病种。

Objective To visualize the current research status,hot spots and trends in the research field of clinical pathway effectiveness home and abroad,and to provide direction and reference for clinical pathway researches in China.Methods Statistical analysis was made of Chinese(English) literature on clinical pathway effectiveness published in CNKI and Web of Science databases since their creation to June 1,2022,and Cite Space 5.8.R3 software was used for visual comparative analysis of authors,institutions,and keywords of valid literature.Results A total of 264 articles in Chinese and 174 articles in English were included.The analysis found that:(1) the number of domestic publications showed a trend of rising and then declining,while the number of foreign publications was generally more stable;(2) domestic researches on clinical pathway effect were mostly independent,while foreign researches had a closer cooperation;(3) the hotspots of domestic researches were mainly health education,effect evaluation,hospitalization cost,length of stay,etc.,while foreign research hotspots were mainly clinical pathway guidelines,hospitalization cost,and clinical care pathways,etc.;(4) Chinese literature on clinical pathway effect can be divided into three evolutionary stages:the start-up stage(2002-2008),the exploration stage(2009-2016),and the development stage(2017-2022),while English literature can be divided into two evolutionary stages:the start-up stage(2003-2011),and the development stage(2012-present).Conclusions China should enhance information management researches,empower with DRG reform,promote elderly care pathways,and further expand trial disease types.